| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/13/2005 | EP1552309A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A CLLD8 PROTEIN |
| 07/13/2005 | EP1552301A2 Methods of screening cyclic peptides and identifying targets therefor |
| 07/13/2005 | EP1552298A2 Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs |
| 07/13/2005 | EP1552002A2 Aptamer-toxin molecules and methods for using same |
| 07/13/2005 | EP1551987A1 Protein modification |
| 07/13/2005 | EP1551985A2 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins |
| 07/13/2005 | EP1551983A2 Identification of e2f target genes and uses thereof |
| 07/13/2005 | EP1551978A2 Nell-1 enhanced bone mineralization |
| 07/13/2005 | EP1551972A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 07/13/2005 | EP1551970A2 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 07/13/2005 | EP1551964A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 07/13/2005 | EP1551963A1 Improved immunotherapy |
| 07/13/2005 | EP1551959A2 Modulators of chloride intracellular channel 1 protein signaling |
| 07/13/2005 | EP1551950A2 Alpha-melanocyte stimulating hormone peptides protection in organ transplantion |
| 07/13/2005 | EP1551927A1 Biological active coating components, coatings, and coated surfaces |
| 07/13/2005 | EP1551872A2 G-protein coupled receptors |
| 07/13/2005 | EP1551870A2 Glycosylated human granulocyte colony-stimulating factor (g-csf) isoform |
| 07/13/2005 | EP1551868A2 Factor involved in metastasis and uses thereof |
| 07/13/2005 | EP1551867A2 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
| 07/13/2005 | EP1551866A1 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a thioredoxin-like 32 kda protein |
| 07/13/2005 | EP1551861A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/13/2005 | EP1551801A1 Novel gamma-lactams as beta-secretase inhibitors |
| 07/13/2005 | EP1551461A2 Azo compounds for type i phototherapy |
| 07/13/2005 | EP1551456A1 Pharmaceutical composition for prevention and treatment of kidney diseases |
| 07/13/2005 | EP1551455A2 Product and process for liquefaction of mucus or sputum |
| 07/13/2005 | EP1551447A2 Anti-addl antibodies and uses thereof |
| 07/13/2005 | EP1551446A1 Neuroendocrine marker for cancer and method for producing same |
| 07/13/2005 | EP1551444A2 Method for treatment of demyelinating central nervous system disease using gm-csf |
| 07/13/2005 | EP1551443A2 Proteins involved in the regulation of energy homeostasis |
| 07/13/2005 | EP1551442A2 Composition for reducing caloric intake |
| 07/13/2005 | EP1551441A1 Peptides and recombinant proteins mimicking interferons |
| 07/13/2005 | EP1551440A2 Uses of human zven proteins and polynucleotides |
| 07/13/2005 | EP1551439A2 Improved systems and methods for analysis of protein post-translational modification |
| 07/13/2005 | EP1551438A2 Analogs of parathyroid hormone and pth-related protein as bone anabolic agents |
| 07/13/2005 | EP1551436A2 Formulations for amylin agonist peptides |
| 07/13/2005 | EP1551435A2 Method for enzymatic production of glp-1 (7-36) amide peptides |
| 07/13/2005 | EP1551434A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/13/2005 | EP1551430A2 Botulinum toxin dental therapies and procedures |
| 07/13/2005 | EP1551426A2 Methods of administering fgf18 |
| 07/13/2005 | EP1551424A1 Treatment of neurological disorders by dsrna adminitration |
| 07/13/2005 | EP1551421A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 07/13/2005 | EP1551383A2 Methods for preventing and treating microbial infections by modulating transcription factors |
| 07/13/2005 | EP1551375A1 Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant |
| 07/13/2005 | EP1551369A2 Combination therapy for treatment of fibrotic disorders |
| 07/13/2005 | EP1551361A1 Oral composition providing enhanced oral hygiene properties |
| 07/13/2005 | EP1551334A2 Medical device for intra-lumenal delivery of pharmaceutical agents |
| 07/13/2005 | EP1551227A2 Preventing secondary lymphedema with vegf-d dna |
| 07/13/2005 | EP1551221A2 Nucleic acid compositions for stimulating immune responses |
| 07/13/2005 | EP1414479A4 Peptide for regulation of tissue plasminogen activator |
| 07/13/2005 | EP1315695B1 Benzene tricarboxylic acid amides as insulin receptor activators |
| 07/13/2005 | EP1042436B1 METHOD OF PREPARING LIPOPROTEINS, LIPOAMINOACIDS, LIPID ESTERS, AND GLUCOLIPIDS FROM the whole constituting fatty acids of OLIVE OIL |
| 07/13/2005 | EP1030567B1 System for dialysis and shock treatment |
| 07/13/2005 | EP1001976B1 Peptides having potassium channel opener activity |
| 07/13/2005 | EP0750512B1 A medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction |
| 07/13/2005 | EP0394296B2 Assay of a body fluid for measuring bone resorption |
| 07/13/2005 | CN1639569A Methods and compositions for inducing an immune response |
| 07/13/2005 | CN1639343A Method for detection of leptin receptor ligands |
| 07/13/2005 | CN1639332A Polynucleotide for target gene |
| 07/13/2005 | CN1639324A Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 07/13/2005 | CN1639322A Recombinant spores |
| 07/13/2005 | CN1639318A Antimicrobial composition |
| 07/13/2005 | CN1639195A Selective targeting of tumor vasculature using antibody molecules |
| 07/13/2005 | CN1639194A Antibodies against cancer |
| 07/13/2005 | CN1639192A Anti-human tenascin monoclonal antibody |
| 07/13/2005 | CN1639191A 鼠李糖结合蛋白 Rhamnose-binding protein |
| 07/13/2005 | CN1639190A Transmembrane NFAT inhibitory peptide |
| 07/13/2005 | CN1639189A Cell apoptosis regulating protein related with heart failure |
| 07/13/2005 | CN1639188A Hepta-, octa- and nonapeptides having antiangiogenic activity |
| 07/13/2005 | CN1639187A Macrocyclic peptides active against the hepatitis C virus |
| 07/13/2005 | CN1639186A Inhibitors of kallikrein |
| 07/13/2005 | CN1639185A Cancer-associated epitope |
| 07/13/2005 | CN1638822A Compositions comprising undifferentiated fetal cells for the treatment of skin disorders |
| 07/13/2005 | CN1638808A Coupling proteins to a modified polysaccharide |
| 07/13/2005 | CN1638807A Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 07/13/2005 | CN1638801A Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof |
| 07/13/2005 | CN1638796A Methods of administering anti-TNF alpha antibodies |
| 07/13/2005 | CN1638795A MVA expressing modified HIV envelope, GAG, and pol genes |
| 07/13/2005 | CN1638793A Pharmaceutical and cosmetic compositions comprising PLGF-1 |
| 07/13/2005 | CN1638792A FGFR agonists |
| 07/13/2005 | CN1638791A Stable pharmaceutical composition comprising erythropoietin |
| 07/13/2005 | CN1638790A Compositions and methods for modulating connexin hemichannels |
| 07/13/2005 | CN1638789A Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (t beta 4), analogues, isoforms and other derivatives |
| 07/13/2005 | CN1638788A Stabilized albumin preparaions |
| 07/13/2005 | CN1638787A Helicobacter pylori adhesion inhibitor |
| 07/13/2005 | CN1638772A Anti-viral compounds |
| 07/13/2005 | CN1638770A Composition and potentiating method |
| 07/13/2005 | CN1638749A Ambroxol for treating painful conditions in the mouth and pharyngeal cavity |
| 07/13/2005 | CN1638747A Sustained release pharmaceutical composition |
| 07/13/2005 | CN1638732A Sustained release drug formulations containing a carrier peptide |
| 07/13/2005 | CN1638650A Composition improving age-related physiological deficits and increasing longevity |
| 07/13/2005 | CN1637020A Polyol-ifn-beta conjugates |
| 07/13/2005 | CN1637018A Novel effectors of dipeptidyl peptidase IV |
| 07/13/2005 | CN1636597A Compounds for the treatment of female sexual dysfunction |
| 07/13/2005 | CN1636595A An EPI-HNE protein dry powder |
| 07/13/2005 | CN1636594A Angiostatin and use of the same for inhibition of angiogenesis |
| 07/13/2005 | CN1636593A Novel effectors of dipeptidyl peptidase IV |
| 07/13/2005 | CN1636592A Stabilized liquid polypeptide-containing pharmaceutical composition |
| 07/13/2005 | CN1636591A Stabilized pharmaceutical composition in lyophilized form |
| 07/13/2005 | CN1636590A Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor |
| 07/13/2005 | CN1636589A Non-aqueous polar aprotic peptide formulations |